MAPT and Alzheimer disease: To conclude, we observed that plasma and CSF GFAP levels associate with Aβ while CSF YKL-40 levels associate with tau pathology, suggesting the existence of astrocyte biomarker signatures of Aβ and tau tangles in the living AD brain.